id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-332237-8oykgp0h	Omrani, Ali S	Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study	2014-09-29		.txt	text/plain	3323	130	44	Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV)-11th update Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study A family cluster of Middle East respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case Hospital outbreak of Middle East respiratory syndrome coronavirus Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection Clinical management of severe acute respiratory infections when novel coronavirus is suspected: what to do and what not to do International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) key: cord-332237-8oykgp0h authors: Omrani, Ali S; Saad, Mustafa M; Baig, Kamran; Bahloul, Abdelkarim; Abdul-Matin, Mohammed; Alaidaroos, Amal Y; Almakhlafi, Ghaleb A; Albarrak, Mohammed M; Memish, Ziad A; Albarrak, Ali M title: Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study date: 2014-09-29 journal: Lancet Infect Dis DOI: 10.1016/s1473-3099(14)70920-x sha: doc_id: 332237 cord_uid: 8oykgp0h BACKGROUND: Middle East respiratory syndrome coronavirus (MERS-CoV) infection is associated with high mortality and has no approved antiviral therapy.	cache/cord-332237-8oykgp0h.txt	txt/cord-332237-8oykgp0h.txt
